# Encompass Health Corporation (EHC) Stock Analysis: A Compelling 27.54% Upside Potential

- Link: https://www.directorstalkinterviews.com/encompass-health-corporation-ehc-stock-analysis-a-compelling-27-54-upside-potential/4121256151
- Published: 2026-07-13T10:23:39+01:00
- Author: Madison Wilson

Encompass Health Corporation (NYSE: EHC), a leading player in the healthcare sector,
specifically in medical care facilities, is drawing significant attention from investors
due to its robust growth potential and attractive valuation metrics. With a market
capitalization of $10.93 billion, EHC is well-positioned within the industry, serving
a critical role in rehabilitative healthcare across the United States and Puerto
Rico. The company is renowned for its specialized inpatient rehabilitation services,
aiding patients in their recovery journey from major injuries or illnesses.

EHC’s current stock price stands at $110.16, reflecting a slight dip of 0.01% recently.
Despite this minor decline, the stock shows promising potential with a 52-week range
between $93.83 and $127.18. The forward price-to-earnings (P/E) ratio of 16.85 suggests
that investors are optimistic about future earnings growth, even though other valuation
metrics such as trailing P/E, PEG ratio, and Price/Book are not available.

One of the standout aspects of Encompass Health’s financial health is its impressive
revenue growth of 9.00%, demonstrating its ability to expand operations and capture
more market share. This is complemented by a return on equity (ROE) of 25.23%, signaling
efficient management and strong profitability. Moreover, the company boasts a solid
free cash flow of $284.1 million, providing a cushion for future investments and
dividends.

Speaking of dividends, Encompass Health offers a modest yield of 0.69% with a conservative
payout ratio of 12.67%. This indicates the company’s prudent approach to reinvesting
earnings for further growth while still rewarding shareholders.

Analysts’ sentiment towards EHC is overwhelmingly positive, with 13 buy ratings 
and no holds or sells. The target price range of $125.00 to $152.00, with an average
target of $140.50, suggests a substantial upside potential of 27.54%. This bullish
outlook is bolstered by technical indicators; the stock’s 50-day moving average 
is $104.02, and the 200-day moving average is $108.05. The relative strength index(
RSI) of 27.74 indicates that the stock may be oversold, potentially presenting a
buying opportunity for savvy investors.

Encompass Health’s strategic focus on inpatient rehabilitation and its extensive
network of hospitals position it well to capitalize on the growing demand for healthcare
services. As the company continues to leverage its expertise and expand its footprint,
investors might find EHC an attractive addition to their portfolios, especially 
given its positive analyst ratings and potential for significant price appreciation.

As the healthcare landscape evolves, Encompass Health’s commitment to enhancing 
patient outcomes through innovative rehabilitative care and strategic partnerships
remains a key driver of its success. For investors seeking exposure to the healthcare
sector with a focus on growth and stability, Encompass Health Corporation emerges
as a compelling option.

Share on: